Tag: Cancer: Leukemia
Blinatumomab Safe, Efficacious for Infants With KMT2A-Rearranged Leukemia
No toxic effects seen meeting definition of primary end point; profile of toxic effects consistent with that reported in older patients
Cancer Risk Increased With Exposure to Four or More CT Scans by Age 18
Increased risk of intracranial tumors, leukemia, and lymphoma by age 25 seen with exposure to four or more CT scans during childhood
Risk of Relapse Increased With Extreme Poverty in Children With Leukemia
Increased risk of relapse seen for children receiving maintenance treatment for acute lymphoblastic leukemia living in extreme poverty
Processed Red Meat Intake Linked to Increased Incidence of Blood Cancers
No associations seen for intake of other foods and fatty acids with acute myeloid leukemia/myelodysplastic syndrome
Variants ID Outcomes in Adults With Leukemia in Relapse Prior to Stem Cell Transplant
Persistence of FLT3-ITD and/or NPM1 in blood associated with relapse and worse survival among acute myeloid leukemia patients
Maternal Infection Linked to Increased Risk for Childhood Leukemia
Significantly increased risk for leukemia seen for children born to mothers with genital and urinary tract infections
Allogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients
Overall survival 64 and 55 percent at one and two years; nonrelapse mortality 20 and 28 percent, respectively
Survival Lower for Children With Leukemia Living on Texas-Mexico Border
Inferior survival seen for children with acute lymphoblastic leukemia, but not acute myeloid leukemia, living on the border
FDA Approves New Drug for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
The next-generation BTK inhibitor zanubrutinib showed greater progression-free survival and fewer side effects in phase 3 trial
2022 ICC Recategorization Facilitates Risk Stratification of Myelodysplastic Syndrome
Distinct mutational landscape and poorer outcomes seen for patients with MDS/acute myeloid leukemia versus MDS not otherwise specified
